TRAIL acts synergistically with iron oxide nanocluster-mediated magneto- and photothermia

Targeting TRAIL (Tumor necrosis factor (TNF)-Related Apoptosis-Inducing Ligand) receptors for cancer therapy remains challenging due to tumor cell resistance and poor preparations of TRAIL or its derivatives. Herein, to optimize its therapeutic use, TRAIL was grafted onto iron oxide nanoclusters (NC...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Theranostics
Autors principals: Belkahla, Hanene, Mazarío, Eva, Sangnier, Anouchka Plan, Lomas, John S., Gharbi, Tijani, Ammar, Souad, Micheau, Olivier, Wilhelm, Claire, Hémadi, Miryana
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2019
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6735372/
https://ncbi.nlm.nih.gov/pubmed/31534529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.36320
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars